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Brief Report
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Abstract
Introduction: We assessed the magnitude of smokeless tobacco (ST) use in Pakistan and identified policy gaps to help ascertain short-, medium-, and long-term priorities. We then elicited stakeholders’ views as to which of these identified priorities are most important.
Methods: In a multimethod study, we: analyzed Global Tobacco Surveillance System data sets to
estimate ST consumption and disease burden; conducted a documentary review to identify gaps
in policies to control ST in comparison with smoking; elicited stakeholders’ views in an interactive
workshop to identify a set of policy options available to address ST burden in Pakistan; and ranked
policy priorities using a postevent survey.
Results: Among all tobacco users in Pakistan (n = 24 million), one-third of men and two-thirds of
women consume ST. In 2017, its use led to an estimated 18 711 deaths due to cancer and ischemic
heart disease. Compared to smoking, policies to control ST lag behind significantly. Priority areas
for ST policies included: banning ST sale to and by minors, advocacy campaigns, introduction of
licensing, levying taxes on ST, and standardizing ST packaging. A clear commitment to close cooperation between state actors and stakeholder groups is needed to create a climate of support
and information for effective policy making.
Conclusions: Smokeless tobacco control in Pakistan should focus on four key policy instruments:
legislation, education, fiscal policies, and quit support. More research into the effectiveness of such
policies is also needed.

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),
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Implications: A number of opportunities to improve ST regulation in Pakistan were identified.
Among these, immediate priorities include banning ST sale to and by minors, mobilizing advocacy
campaign, introduction of licensing through the 1958 Tobacco Vendors Act, levying taxes on ST,
and standardizing ST packaging.

Smokeless tobacco (ST) is consumed by approximately 356 million
people (one-fourth of all tobacco users) in 140 countries.1 In 29 of
these countries, more than 10% of the population uses ST regularly.2 Regulated poorly,2 ST products vary in their composition and
health risks. Most of these products, particularly in low- and middleincome countries (LMICs),3 contain high levels of nicotine and nitrosamines, leading to dependence and a high incidence of head and
neck cancers, respectively.4 ST products are also associated with cardiovascular deaths5 and, if consumed during pregnancy, with poor
birth outcomes.6 The burden of disease due to ST use is particularly
high in Asia and Africa,3,7 where the poorest sectors of society bear
the greatest burden.1
Despite being signatories to the World Health Organization
(WHO) Framework Convention for Tobacco Control (FCTC), there
is substantial disparity in policy development and implementation between smoking and ST products.2 As a consequence, progress to curb
ST consumption is falling behind that for smoking.2 In Pakistan—a
high tobacco burden country—ST products are popular, cheap, and
easily available.8 Unlike cigarettes, ST consumption is also common
and socially acceptable among women and young people.9 Recently,
several academics, civil society organizations, and statutory bodies
from Pakistan have joined a new initiative called Addressing ST and
building Research capacity in south Asia (ASTRA).10 On behalf of
ASTRA, we conducted a multimethod analysis to identify policy challenges, opportunities, and priorities to improve its regulation.

Methods
We: (1) analyzed secondary data to describe ST use prevalence and
estimate its disease burden; (2) reviewed documents to compare
policies for controlling ST with those for smoking; (3) convened
an interactive consultation to elicit stakeholders’ views to identify
a set of policy options available to address ST; and (4) conducted a
postevent survey to determine the most important policy priorities.

Secondary Data Analysis
We analyzed Global Adult Tobacco Survey11 (GATS) 2014 and
Global Youth Tobacco Survey12 (GYTS) 2013 to compare distributions of ST use with smoking. The disease burden attributable to ST
use was estimated as a proportion of the burden reported in the 2017
Global Burden of Disease study.13 For this, we used comparative risk
assessment method—also used previously to estimate global burden
of disease due to ST.3 Exposure to ST was extrapolated from GATS,11
and disease-specific risk estimates for cancers and cardiovascular diseases were obtained from previously published meta-analyses.3,5

Documentary Review
We undertook a comparative documentary review to highlight differences in policies between smoking and ST. We reviewed all tobaccorelated legislative documents and Statutory Regulatory Orders
(SROs) issued in the last 20 years by the then Ministry of Health and
Ministry of National Health Services, Regulations and Coordination

Pakistan (NHSRC).14 We also reviewed summaries of the legislation
available on tobacco control laws web site.15 Moreover, we analyzed
GATS11 data to assess the extent to which advice and support is
offered to ST users in comparison with smokers.

Priority Setting Workshop
We shared the findings of the above two studies at a 2-day stakeholders’ workshop. We invited a total of 28 policy makers, academics, and advocates at this event and organized discussions
around five themes:16 fiscal policies, product regulation, education
and awareness, cessation support, and knowledge gaps. Following
the initial brainstorming and discussion at the event, a consensus
development approach was undertaken to identify and agree on key
priorities to address ST use. After the event, the key priorities were
shared with all 28 stakeholders for feedback.

Postevent Survey
Postworkshop, the stakeholders used an online survey to rank
these policies on a five-point scale in terms of their priority level.
Stakeholder’s responses were pooled to generate mean scores for the
policy options and ranked accordingly.

Results
Prevalence of ST Use and Associated Disease Burden
Over 9.6 million adults (7.7% overall, 11.4% males, 3.7% females)
in Pakistan consume ST regularly; this constitutes approximately
one-third (35.6%) of all male tobacco users and up to two-thirds
(62.8%) of all females’ tobacco users. Among adolescents aged
13–15 years, up to 54.0% of tobacco users consume ST, with estimates of current use being 6.4% and 3.7% in males and females,
respectively. Naswar is by far the most commonly used ST product,
followed by tobacco containing paan and gutkha.
The overall disease burden attributable to ST was based on
the risk of mouth (relative risk [RR] 5.2), pharyngeal (RR 2.6)
and esophageal (RR 2.6) cancers, and ischemic heart disease (RR
1.57).3 We estimated that, in 2017, approximately 18 711 deaths
and 200 638 disability-adjusted life years (DALYs) in Pakistan were
attributed to ST users. A third of this disease burden was estimated
to be due to cancers and two-thirds due to ischemic heart disease.

Policy Gaps in Relation to ST
Table 1 lists the tobacco control laws in Pakistan, identifying the
differences between smoking and ST. Other than restricting general
advertisement and sale within the vicinity of educational institutions, all other laws have not been applied to ST, indicating a wide
disparity in the way the two types of tobacco use are dealt with.
Further analysis of GATS results (Figure 1) found that health professionals are less likely to inquire about individuals’ ST use as compared to cigarette use and also less likely to offer advice, behavioral
support, or medication to help them quit (Figure 1). On the other
hand, knowledge and awareness of health-related harms of tobacco
use were lower among ST users (77.0%) than in smokers (86.0%).
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Table 1. A comparative analysis of tobacco control laws in
Pakistan for both smoking and smokeless tobacco

% offered other support
% offered medicaon
% offered behavioural support

Requirements to have nicotine and tar contents
on the label
Requirements to have excise stamp, affixing
banderols on the pack
Prohibition on quantity, i.e., sale less than 20
per pack
Smoke-free laws

No

No

% advised to quit on their own

No

No

Yes

No

Yes

Warning labels on packs
Restriction on advertisement of tobacco
Promotion of samples to minors
Prohibition of sale of tobacco to minors and by
minors
Prohibition of storage, sale, and distribution
of tobacco in the immediate vicinity of
educational institutions

Yes
Yes
Yes
Yes

Not
applicable
No
Yes
No
No

Yes

Yes

Tobacco control laws in Pakistan

Barriers and Opportunities
In the stakeholders’ workshop (attended by 19/28 invitees), there
was acknowledgment of the gaps in ST regulations and the need to
reduce ST-related burden. Participants recognized that ST is manufactured primarily in the informal sector in Pakistan, which made it
challenging to tax and regulate. However, unlike cigarettes, this also
made any direct industry interference less likely in response to any
policy action(s). Other barriers included lack of awareness of the
ST-related health risks among policy makers and legislators, variations in packaging of ST products, little understanding of its supply
chain, and an absence of evidence on cessation strategies. It was also
recognized that, over the long term, policies to reduce ST use should
include encouraging alternative livelihoods for producers.

Policy Priorities
The following priorities were identified (and ranked by 20/28):
1. Fiscal policies: Ninety percent considered the enactment of the
1958 Tobacco Vendor Act that mandates licensing for all tobacco
sellers as high priority. Seventy-five percent considered levying
taxes at a minimum of 70% of the retail price, implementing tax
track and trace and earmarking tobacco tax for providing alternative livelihoods as high priorities.
2. Cessation services: There was a significant majority of participants who considered the formulation of national guidelines
for treating tobacco dependence (80%), integrating tobacco dependence treatment within existing health systems (75%), and
incorporating it within health professionals’ curriculum (70%)
should receive high priority. A comprehensive service to treat tobacco dependence was considered a long-term goal.
3. Education and awareness: A comprehensive media campaign
to raise public awareness about ST (90%) and building an
antitobacco advocacy coalition of legislators, health professional, journalists, cancer charities, and patient support groups
should be the highest priority (90%), followed by antitobacco
messages within educational institutions and curricula (80%).
4. Product regulation: Everyone agreed that a ban on ST product
sale to and by minors should be introduced immediately. Seventy
percent considered standardizing ST packaging and labeling

% advised to quit
% asked about tobacco use
% visited health worker in last 12…
0

10

smokeless tobacco

20

30

40

50

smokers

Figure 1. A comparison between smokers and smokeless tobacco users in
the way they are advised by health professionals in the last 12 months.

including mandating pictorial warnings and formalizing industry
by introducing licensing should be a high priority. It was agreed
that manufacturers requiring disclosure of their ingredients and
regular inspections and laboratory testing could be introduced at
a later stage.
5. Research priorities: These included an estimation of the economic and disease burden of ST use and the return on investment
in addressing it. Others included documenting all ST products
and their composition available in Pakistan, their market share,
and points in the supply chain where taxes can be levied.

Discussion
ST products are commonly used in Pakistan and impact different
segments of population, including women and people of low
socioeconomic status. Products consumed are known to contain high
levels of nicotine and nitrosamines, which are linked to wide-ranging
harms including specific types of cancers (head and neck), cardiovascular diseases, and poor perinatal outcomes. The profile of ST products in Pakistan is in contrast with those in Nordic countries, where
available ST products have low nitrosamine levels and pose fewer
health risks.17 Moreover, unlike smoking, ST has received little attention so far. This is the first priority setting exercise that we know
of to provide a list of policy actions to address ST use in Pakistan.
Among all 140 countries where ST is consumed, Pakistan is
among the top three countries with the highest ST-related disease
burden, superseded only by India and Bangladesh.3 A recent global
policy review2 highlighted that a majority of the 140 countries have
not yet put comprehensive tobacco control measures covering ST
use in place. Only a handful of countries levy taxes up to 70% of
their retail price, inspect their contents, ban advertising, or warn
their populations of ST-related harms. That said, Pakistan could
learn lesson from India where some policy action has happened to
curb ST use, including effective advocacy led by civil society in India,
leading to the introduction of strong pictorial warnings, use of Food
Safety and Standards Act, 2006, to ban gutkha sale, levying tax on
ST manufacturing units, and prohibiting ST use as an ingredient
within tooth cleaning products.18

Limitations
Our disease burden figures are conservative and are derived from risk
estimates based on ST use in Pakistan and other countries.3,5 The stakeholders’ views included in this study come from a nonrandom sample
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Implications
The policy priorities identified in our analysis are similar to global
priorities for ST,2 for example, taxation, standardization of packaging,
educational campaigns, training health professionals in treating ST dependence, preventing the sale by and to minors, and monitoring the
health and economic impact. Were even some of these policies to be
adopted, it is likely that the impact of ST on health outcomes would
be reduced, though research will, of course, be needed to establish
which interventions produce the most significant health impact. With
this in mind, the above analysis was also useful in orientating ASTRA’s
future research direction in line with the knowledge gaps identified
by the stakeholders and in building capacity and generating demand
for further research—one of ASTRA’s objectives. For all affected communities, it is hoped that this exercise will generate momentum for a
multisectorial effort to address ST as a public health issue.
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of workshop and postevent survey participants. They include a cross
section of wider stakeholder group (health advocates, health care providers, and researchers) within Pakistan’s health sector. Policy makers’
views may be underrepresented; this is a gap ASTRA will address in
the near future. However, the policy elicitation process was facilitated
by international experts and supported by health professionals from
Pakistan who are knowledgeable and experienced in the field. Despite
its limitations, it constitutes the first initiative to consolidate and coordinate research and advocacy expertise in ST use in Pakistan.
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